Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Protacs in Gynecological Cancers: Current Knowledge and Future Potential As a Treatment Strategy Publisher Pubmed



Movahed F1 ; Ourang Z2 ; Neshat R3 ; Hussein WS4 ; Saihood AS5 ; Alarajy MS6 ; Zareii D7
Authors

Source: Pathology, research and practice Published:2024


Abstract

Cancer continues to threaten human health regardless of novel therapeutic options. Over the last two decades, targeted therapy has emerged as a significant advancement in treating malignancies, surpassing standard chemoradiotherapy and surgical procedures. Gynecological malignancies, including cervical, endometrial, and ovarian carcinoma, have a bad prognosis in advanced or metastatic stages and are difficult to treat. The advancements in understanding the molecular pathways behind cancer development offer valuable insights into promising targeted medicines, and researchers have always searched for a superior and safe technique to target cancer-related oncoproteins because of the limited therapeutic benefit, drug resistance, and off-target effects of current targeted treatments. Recently, proteolysis-targeting chimeras (PROTACs) have been developed to selectively degrade proteins using the natural ubiquitin-proteasome system (UPS). These approaches have garnered significant attention in the field of cancer research. The rapid progress in PROTACs has also eased the targeting of various oncoproteins in gynecological cancer. Therefore, this review aims to elucidate the mechanism and research advancements of PROTACs and provide a comprehensive overview of their use in gynecological tumors. Copyright © 2024 Elsevier GmbH. All rights reserved.
Related Docs
View other Related Docs
1. Effects of Chitosan and Oligochitosans on the Phosphatidylinositol 3-Kinase-Akt Pathway in Cancer Therapy, International Journal of Biological Macromolecules (2020)
2. Synthesis and Biological Evaluation of Novel Anti-Leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase, Iranian Journal of Pharmaceutical Research (2022)
3. Can Anticancer Drugs Be a Promising Candidate for the Treatment of Endometriosis?, Cell Journal (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Mansournia (3)
Fatemeh Atyabi (2)
Other Related Docs
4. Chitosan-Based Materials and Strategies in Immunotherapy and Synergistic Immunochemotherapy: A Focus on Gene-Based Immunoregulation and Car-T and Adoptive Cell Transfer, Carbohydrate Polymer Technologies and Applications (2025)
5. Car-Nk Cell in Cancer Immunotherapy; a Promising Frontier, Cancer Science (2021)
6. Macrophage’S Role in Solid Tumors: Two Edges of a Sword, Cancer Cell International (2023)
7. Regulation of Ubiquitin-Proteasome System and Its Relative Pathways in Pancreatic Adenocarcinoma, BioImpacts (2025)
8. Effects of Silibinin on Growth and Invasive Properties of Human Ovarian Carcinoma Cells Through Suppression of Heregulin/Her3 Pathway, Tumor Biology (2016)
9. The Effects of Chitosan-Based Materials on Glioma: Recent Advances in Its Applications for Diagnosis and Treatment, International Journal of Biological Macromolecules (2021)
10. Hersintuzumab: A Novel Humanized Anti-Her2 Monoclonal Antibody Induces Potent Tumor Growth Inhibition, Investigational New Drugs (2018)
11. Comprehensive Analysis of the Role of Ubiquitin-Specific Peptidases in Colorectal Cancer: A Systematic Review, World Journal of Gastrointestinal Oncology (2024)
12. Sirna and Epigenetic Aberrations in Ovarian Cancer, Journal of Cancer Research and Therapeutics (2016)
13. Evaluation of the Effects of Rationally Designed Anti-Trkb Peptides on the Proliferation and Apoptosis of Multiple Myeloma Cells, International Journal of Bioinformatics Research and Applications (2016)
14. Beta-Glucans Is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects, Current Pharmaceutical Biotechnology (2022)
15. A Review on Targeting Tumor Microenvironment: The Main Paradigm Shift in the Mab-Based Immunotherapy of Solid Tumors, International Journal of Biological Macromolecules (2022)
16. Aptamer-Functionalized Chitosan-Coated Gold Nanoparticle Complex As a Suitable Targeted Drug Carrier for Improved Breast Cancer Treatment, Nanotechnology Reviews (2022)
17. Interplay Between Proteasome Inhibitors and Nf-Κb Pathway in Leukemia and Lymphoma: A Comprehensive Review on Challenges Ahead of Proteasome Inhibitors, Cell Communication and Signaling (2024)
18. The Impact of the Codelivery of Drug-Sirna by Trimethyl Chitosan Nanoparticles on the Efficacy of Chemotherapy for Metastatic Breast Cancer Cell Line (Mda-Mb-231), Artificial Cells# Nanomedicine and Biotechnology (2017)
19. The Role of Genistein and Its Derivatives in Ovarian Cancer: New Perspectives for Molecular Mechanisms and Clinical Applications, Current Medicinal Chemistry (2025)
20. Inhibition of Cd73 Using Folate Targeted Nanoparticles Carrying Anti-Cd73 Sirna Potentiates Anticancer Efficacy of Dinaciclib, Life Sciences (2020)